← Leaderboards
Binfeng Lu
University Of Pittsburgh At Pittsburgh
$6,521,286
Attributed
$7,445,292
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $826.6K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,445,292 · 8
By mechanism
R01$5,322,646 · 3
R21$1,523,171 · 4
K01$599,475 · 1
Top collaborators
- Song Li6 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Qimin Zhan$1,628,773
- Joel S Greenberger$22,565,586
- Derek A Pociask$2,330,869
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsImmuneFamilyCytokineMediatingMemberSignal TransductionInfectionResponseCd4 Positive T LymphocytesMolecularTumor MicroenvironmentNeoplastic CellTumorTumor GrowthCd8b1 GeneCancer ImmunotherapyInterleukin-1Mouse ModelCancer TherapyTh1 CellsTissuesRegulatory T-LymphocyteNeoplasm Immunotherapy
Grant awards (30)
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy$401,113
R01 · FY2025 · CA · contact PI
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy$381,058
R01 · FY2024 · CA · contact PI
Study of Interleukin 33 as a new immunotherapy of lung cancer$433,485
R01 · FY2023 · CA · contact PI
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy$393,090
R01 · FY2023 · CA · contact PI
Study of Interleukin 33 as a new immunotherapy of lung cancer$266,925
R01 · FY2022 · CA · contact PI
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy$244,207
R01 · FY2022 · CA · contact PI
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy$132,998
R01 · FY2022 · CA · contact PI
Study of Interleukin 33 as a new immunotherapy of lung cancer$81,376
R01 · FY2022 · CA · contact PI
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy$396,116
R01 · FY2021 · CA · contact PI
Study of Interleukin 33 as a new immunotherapy of lung cancer$355,409
R01 · FY2021 · CA · contact PI
Study of Interleukin 33 as a new immunotherapy of lung cancer$355,409
R01 · FY2020 · CA · contact PI
Study of Interleukin 33 as a new immunotherapy of lung cancer$355,409
R01 · FY2019 · CA · contact PI
Targeting IL-33 to boost immunotherapy of cancer$165,087
R21 · FY2019 · CA · contact PI
Targeting IL-33 to boost immunotherapy of cancer$203,580
R21 · FY2018 · CA · contact PI
Dissecting the role of the ATF4 stress response in T cell-mediated inflammation$232,500
R21 · FY2017 · AI · contact PI
Exploring IL-36gamma as a new tumor immune therapy$168,699
R21 · FY2017 · CA · contact PI
Exploring IL-36gamma as a new tumor immune therapy$200,970
R21 · FY2016 · CA · contact PI
Dissecting the role of the ATF4 stress response in T cell-mediated inflammation$192,500
R21 · FY2016 · AI · contact PI
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity$193,991
R21 · FY2014 · CA · contact PI
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity$165,844
R21 · FY2013 · CA · contact PI
Immune Regulation by Gadd45b and Gadd45g$298,624
R01 · FY2010 · AI · contact PI
Immune Regulation by Gadd45b and Gadd45g$301,640
R01 · FY2009 · AI · contact PI
Immune Regulation by Gadd45b and Gadd45g$301,640
R01 · FY2008 · AI · contact PI
Immune Regulation by Gadd45b and Gadd45g$307,482
R01 · FY2007 · AI · contact PI
Regulation of the MAP kinase pathway in the CD4+ T cells$119,895
K01 · FY2007 · AR · contact PI
Immune Regulation by Gadd45b and Gadd45g$316,665
R01 · FY2006 · AI · contact PI
Regulation of the MAP kinase pathway in the CD4+ T cells$119,895
K01 · FY2006 · AR · contact PI
Regulation of the MAP kinase pathway in the CD4+ T cells$119,895
K01 · FY2005 · AR
Regulation of the MAP kinase pathway in the CD4+ T cells$119,895
K01 · FY2004 · AR
Regulation of the MAP kinase pathway in the CD4+ T cells$119,895
K01 · FY2003 · AR